April 30, 2024
Project Profiles Global Health

Pharmaceutical Partner Introducing New Sterile Vaccine Product

HIPRA, an EU-based biopharma company, was developing a recombinant protein vaccine against SARS-COV-2 and was looking for an experienced partner to work with in order to improve the adoption of its vaccine in global markets.